By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

National Institute of Allergy And Infectious Diseases (NIAID) 

31 Center Drive MSC 2520
Building 31, Room 7A-50
Bethesda  Maryland  20892-2520  U.S.A.
Phone: 301-496-5717 Fax:


SEARCH JOBS


Industry
Healthcare


Collaborations

MedImmune, LLC 

MedImmune 





Company News
Symbiotix Biotherapies Announces $2.3 Million Award From NIH's National Institute of Allergy And Infectious Diseases (NIAID) 6/1/2015 8:39:25 AM
Anaheim Clinical Trials (ACT) Phase I Clinical Trial Center Selected As A Subcontractor In NIH/National Institute of Allergy And Infectious Diseases (NIAID)’s Therapeutics Against Infectious Disease Initiative 5/27/2015 12:54:44 PM
Emergent BioSolutions (EBS) Signs Agreements With Oxford University, GlaxoSmithKline (GSK), And National Institute of Allergy And Infectious Diseases (NIAID) For The Production Of An MVA Ebola Zaire Vaccine Candidate 3/16/2015 7:20:15 AM
Inovio Pharmaceuticals (INO) And Academic Collaborators Receive $16 Million HIV Grant From National Institute of Allergy And Infectious Diseases (NIAID) 3/16/2015 7:18:20 AM
Why Women May Have More Serious Allergic Reactions Than Men, National Institute of Allergy And Infectious Diseases (NIAID) Study 12/30/2014 6:29:43 AM
J. Craig Venter Institute Key Member Of Team Awarded Up To A 5-Year, $23 Million Contract From National Institute of Allergy And Infectious Diseases (NIAID) For Renewal Of Bioinformatics Resource Centers For Infectious Diseases Viral Project 11/11/2014 9:59:19 AM
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million 9/19/2014 6:25:08 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014 11:20:04 AM
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014 7:20:58 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of OrbeShield™ In GI ARS 8/1/2014 7:14:57 AM
12345678910...
//-->